a year ago

Amethyst Radiotherapy Secures €300 Million Funding from Ares Management

  • Amethyst Radiotherapy, a Pan European oncology company, has secured €300 million in financing from Ares Management Corporation

  • This investment will enable Amethyst to expand its operations across Europe and bring innovative cancer care to more patients.

      • ProblemHealthcare

      "Access to high-quality and affordable cancer care is limited in Europe, leaving many patients without adequate treatment options. "

      Solution

      "Amethyst Radiotherapy provides state-of-the-art cancer treatment across Europe through a network of 15 centers. They are dedicated to improving health outcomes for cancer patients and to providing an innovative and supportive environment for healthcare professionals."

      Covered on